Safety profile of triple ICS/LABA/LAMA FDC in the treatment of asthma: a meta-analysis

被引：0
|
作者：
Calzetta, L. [1 ]
Cavalli, F. [2 ]
Chetta, A. [1 ]
Cazzola, M. [2 ]
Rogliani, P. [2 ]
机构：
[1] Univ Parma, Parma, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
Asthma; Pharmacology; Treatments;
D O I：
10.1183/13993003.congress-2022.294
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
294
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of ICS/LABA/LAMA FDCs in COPD: a network meta-analysis
    Rogliani, P.
    Cazzola, M.
    Verri, S.
    Camardelli, F.
    Calzetta, L.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [2] Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
    Rogliani, Paola
    Cavalli, Francesco
    Chetta, Alfredo
    Cazzola, Mario
    Calzetta, Luigino
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 565 - 577
  • [3] Predictors of treatment response to high-dose ICS/LABA or medium-dose ICS/LABA plus LAMA in asthma patients - TAILOR study
    Verhamme, K. M.
    De Ridder, M.
    Rijnbeek, P.
    Mosseveld, M.
    Pedersen, L.
    Marconi, E.
    Lapi, F.
    Tan, C.
    Delmestri, A.
    Prieto-Alhambra, D.
    Nudo, E.
    Brusselle, G.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [4] Step up to ICS/LAMA/LABA vs switch to LAMA/LABA in patients with COPD on ICS/LABA: post hoc analysis of KRONOS
    Singh, Dave
    Bafadhel, Mona
    Bowen, Karin
    Arya, Niki
    Marshall, Jonathan
    Parikh, Himanshu
    Patel, Mehul
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [5] Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis
    Rogliani, Paola
    Calzetta, Luigino
    Ora, Josue
    Cazzola, Mario
    Matera, Maria Gabriella
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [6] Temporal trend of benralizumab safety profile in severe asthma: a cumulative meta-analysis
    Calzetta, L.
    Ora, J.
    Cavalli, F.
    Laitano, R.
    Rogliani, P.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [7] Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement
    Laitano, Rossella
    Calzetta, Luigino
    Matino, Matteo
    Pistocchini, Elena
    Rogliani, Paola
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (08) : 1071 - 1081
  • [8] Efficacy and safety profile of doxofylline in asthma: a meta-analysis
    Gao, Fa
    Li, Jian
    Hou, Yulong
    Sun, Shuxin
    Chen, Yiyuan
    Cao, Fang
    Xu, Hang
    Li, Jing
    JOURNAL OF ASTHMA, 2025, 62 (02) : 205 - 215
  • [9] Baseline Characteristics and ICS/LAMA/LABA Response in Asthma: Analyses From the CAPTAIN Study
    Boulet, Louis -Philippe
    Abbott, Carl
    Brusselle, Guy
    Edwards, Dawn
    Oppenheimer, John
    Pavord, Ian D.
    Pizzichini, Emilio
    Sagara, Hironori
    Slade, David
    Wechsler, Michael E.
    Gibson, Peter G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (05) : 1244 - 1253.e8
  • [10] Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
    Plaza, Vicente
    Dominguez-Ortega, Javier
    Gonzalez-Segura Alsina, Diego
    Lo Re, Daniele
    Sicras-Mainar, Antoni
    PHARMACEUTICALS, 2023, 16 (11)
12345